Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Andrea K. Ng"'
Autor:
Sanjay Divakaran, Diana M. Lopez, Sean M. Parks, Jon Hainer, Andrea K. Ng, Ron Blankstein, Marcelo F. Di Carli, Anju Nohria
Publikováno v:
Cardio-Oncology, Vol 9, Iss 1, Pp 1-13 (2023)
Abstract Background Consensus guidelines recommend periodic screening for coronary artery disease (CAD) in Hodgkin lymphoma (HL) survivors treated with radiation therapy (RT) to the chest. However, the prognostic utility of screening strategies in th
Externí odkaz:
https://doaj.org/article/754c3da2d46b40c0884da95d406c004b
Autor:
Hazim S. Ababneh, Andrea K. Ng, Matthew J. Frigault, Jeremy S Abramson, Patrick Connor Johnson, Caron A. Jacobson, Chirayu G. Patel
Publikováno v:
Haematologica, Vol 108, Iss 11 (2023)
Despite the success of CD19-targeted chimeric antigen receptor (CAR T)-cell therapy in patients with relapsed/refractory large B-cell lymphoma (LBCL), there is a need for effective salvage strategies post-CAR T-cell therapy failure. We conducted a mu
Externí odkaz:
https://doaj.org/article/4a2ced42a6da469fb8f751f77f667624
Autor:
Bouthaina Shbib Dabaja, David Boyce-Fappiano, Wenli Dong, Ethan Damron, Penny Fang, Jill Gunther, Maria A. Rodriguez, Paolo Strati, Raphael Steiner, Ranjit Nair, Hun Lee, Zeinab Abou Yehia, Ferial Shihadeh, Chelsea Pinnix, Andrea K. Ng
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 35, Iss , Pp 64-69 (2022)
Purpose: Therapeutic improvements for Hodgkin’s Lymphoma (HL) has resulted in excellent survival outcomes. Thus, patients are increasing susceptible to developing secondary malignancy (SM) a feared iatrogenic complication. Materials & Methods: We e
Externí odkaz:
https://doaj.org/article/a4338188d5c948ccbd8d7d5d7a1b4869
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract The influence of socioeconomic status (SES) on access to standard chemotherapy and/or monoclonal antibody therapy, and associated secular trends, relative survival, and excess mortality, among diffuse large B-cell lymphoma (DLBCL) patients i
Externí odkaz:
https://doaj.org/article/44933f225a014fc7adbe380c4e55a037
Autor:
Chelsea C. Pinnix, Andrea K. Ng, Bouthaina S. Dabaja, Sarah A. Milgrom, Jillian R. Gunther, C. David Fuller, Grace L. Smith, Zeinab Abou Yehia, Wei Qiao, Christine F. Wogan, Mani Akhtari, Osama Mawlawi, L. Jeffrey Medeiros, Hubert H. Chuang, William Martin-Doyle, Philippe Armand, Ann S. LaCasce, Yasuhiro Oki, Michelle Fanale, Jason Westin, Sattva Neelapu, Loretta Nastoupil
Publikováno v:
Blood Advances, Vol 2, Iss 11, Pp 1334-1343 (2018)
Abstract: Dose-adjusted rituximab plus etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (DA-R-EPOCH) has produced good outcomes in primary mediastinal B-cell lymphoma (PMBCL), but predictors of resistance to this treatment are un
Externí odkaz:
https://doaj.org/article/b3c2037dc536496485bae569faf37b09
Autor:
Paul E. Wallner, Anthony M. Gerdeman, Lydia Warg, Meckenzie B. Fussell, Scott Segal, Kristin Gudenkauf, David Laszakovits, Mathew Bunting, Brian J. Davis, Andrea K. Ng, John H. Suh, Catheryn M. Yashar, Kaled M. Alektiar, Brent J. Wagner
Publikováno v:
Journal of the American College of Radiology. 19:663-668
With the onset of the global coronavirus disease 2019 pandemic in early 2020, it became apparent that routine administration of the ABR Qualifying and Certifying Exams would be disrupted. Initial intent for postponement was later altered to a recogni
Publikováno v:
Oncology (Williston Park, N.Y.). 36(12)
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma. Historically, radiation therapy (RT) served as the primary treatment modality for patients with localized disease. While still an option for select patients who
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports
Scientific Reports
The influence of socioeconomic status (SES) on access to standard chemotherapy and/or monoclonal antibody therapy, and associated secular trends, relative survival, and excess mortality, among diffuse large B-cell lymphoma (DLBCL) patients is not cle
Autor:
Carmen Bergom, Andrea K. Ng, Joshua D. Mitchell, Julie A. Bradley, Clifford G. Robinson, Juan Lopez-Mattei, Pamela Samson
Publikováno v:
JACC: CardioOncology
Radiation therapy is an important component of cancer therapy for many malignancies. With improvements in cardiac-sparing techniques, radiation-induced cardiac dysfunction has decreased but remains a continued concern. In this review, we provide an o
Autor:
Kaled M. Alektiar, Brian J. Davis, Paul E. Wallner, John H. Suh, Andrea K. Ng, Catheryn M. Yashar
Publikováno v:
Practical Radiation Oncology. 12:103-105